Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Peptides ; 30(2): 385-90, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18951935

RESUMO

This study investigated plasma brain natriuretic peptide (BNP) levels in normotensive and hypertensive patients with suspected coronary artery disease during radionuclide pharmacological stress testing. Twenty-seven normotensive patients (15 males, aged 63.0+/-4.5 years and 12 females, aged 63.0+/-4.1 years) and 38 essential hypertensive patients (25 males, aged 63.3+/-3.3 years and 13 females, aged 64.6+/-2.6 years) with chest pain and exercise stress testing inconclusive for coronary artery disease underwent myocardial perfusion single-photon emission computed tomography (SPECT) using adenosine infusion. SPECT identified patients without (16 normotensive and 22 hypertensive) and patients with (11 normotensive and 16 hypertensive) transient perfusion defects. Basal BNP levels in normotensive patients without transient myocardial ischemia (3.1+/-1.2 fmol/ml) were significantly (P<0.01) lower than those observed in normotensive patients with transient ischemia (8.2+/-1.2 fmol/ml), whereas BNP levels in hypertensive patients without transient ischemia (8.2+/-1.0 fmol/ml) did not significantly differ from those in hypertensive patients with transient ischemia (8.1+/-2.0 fmol/ml). No significant difference was found in BNP levels between males or females either in normotensive or hypertensive patients without or with ischemia. Adenosine infusion did not significantly change BNP levels in any subject group without or with myocardial perfusion defects. Our findings show that increases in BNP allow early detection of myocardial ischemia in normotensive patients, but not in hypertensive patients with suspected coronary artery disease. Adenosine-induced myocardial ischemia does not affect BNP production already activated by coronary artery disease in normotensive patients and by hemodynamic changes in hypertensive patients.


Assuntos
Adenosina , Doença da Artéria Coronariana/diagnóstico , Hipertensão/complicações , Isquemia Miocárdica/diagnóstico , Peptídeo Natriurético Encefálico/sangue , Tomografia Computadorizada de Emissão de Fóton Único , Idoso , Doença da Artéria Coronariana/complicações , Doença da Artéria Coronariana/diagnóstico por imagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Isquemia Miocárdica/induzido quimicamente , Isquemia Miocárdica/diagnóstico por imagem
2.
J Med Chem ; 51(6): 1592-600, 2008 Mar 27.
Artigo em Inglês | MEDLINE | ID: mdl-18303827

RESUMO

The synthesis, characterization, and functional in vitro assays in cardiac tissues and smooth muscle (vascular and nonvascular) of a number of 4-imidazo[2,1- b]thiazole-1,4-dihydropyridines are reported. The binding properties for the novel compounds have been investigated and the interaction with the binding site common to other aryl-dihydropyridines has been demonstrated. Interestingly, the novel 4-aryl-dihydropyridines are L-type calcium channel blockers with a peculiar pharmacological behavior. Indeed, the imidazo[2,1- b]thiazole system is found to confer to the dihydropyridine scaffold an inotropic and/or chronotropic cardiovascular activity with a high selectivity toward the nonvascular tissue. Finally, molecular modeling studies were undertaken for the most representative compounds with the aim of describing the binding properties of the new ligands at molecular level and to rationalize the found structure-activity relationship data. Due to the observed pharmacological behavior of our compounds, they might be promising agents for the treatment of specific cardiovascular pathologies such as cardiac hypertrophy and ischemia.


Assuntos
Di-Hidropiridinas/farmacologia , Frequência Cardíaca/efeitos dos fármacos , Coração/efeitos dos fármacos , Imidazóis/farmacologia , Contração Miocárdica/efeitos dos fármacos , Tiazóis/farmacologia , Animais , Sítios de Ligação , Simulação por Computador , Di-Hidropiridinas/síntese química , Di-Hidropiridinas/química , Desenho de Fármacos , Avaliação Pré-Clínica de Medicamentos , Cobaias , Imidazóis/síntese química , Imidazóis/química , Ligantes , Modelos Moleculares , Estrutura Molecular , Músculo Liso Vascular/efeitos dos fármacos , Miócitos Cardíacos/efeitos dos fármacos , Bibliotecas de Moléculas Pequenas , Relação Estrutura-Atividade , Tiazóis/síntese química , Tiazóis/química
3.
Peptides ; 26(12): 2487-90, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16029910

RESUMO

We studied circulating levels of endothelin-1, catecholamines and nitric oxide after a mental arithmetic test in 14 patients with early ischemic lesions of the extremities due to systemic sclerosis and slightly impaired peripheral vascular flow. The test induced an increase (P<0.01) in blood pressure, heart rate, endothelin-1 and catecholamine levels, whereas it did not change the low basal levels of nitric oxide. In healthy subjects (n=20) the test significantly (P<0.01) decreased endothelin-1 without affecting nitric oxide. The low basal levels of nitric oxide and the high plasma concentration of endothelin-1 after psychological stress cannot be explained by an impaired release from the limited ischemic lesions alone. This suggests a diffuse microvascular derangement that aggravates the course of peripheral microvascular ischemic lesions.


Assuntos
Endotelina-1/sangue , Isquemia/sangue , Óxido Nítrico/sangue , Escleroderma Sistêmico/sangue , Estresse Psicológico/sangue , Adulto , Idoso , Pressão Sanguínea , Feminino , Frequência Cardíaca , Humanos , Isquemia/complicações , Masculino , Pessoa de Meia-Idade , Testes Psicológicos , Escleroderma Sistêmico/complicações
4.
Eur J Neurosci ; 21(1): 46-58, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15654842

RESUMO

The repressor element-1 (RE-1) silencing transcription factor (REST) interacts with an RE-1 cis element and represses the transcription of neuron-specific genes in neuronal progenitors but is down-regulated in post-mitotic neurons. We report that REST expression is modified, in a time-dependent manner, in SH-SY5Y neuroblastoma cells exposed to insulin-like growth factor I (IGF-I), a polypeptide hormone affecting various aspects of neuronal induction and maturation. REST is increased in cells treated with IGF-I for 2 days and then declines in 5-day-treated cells concomitant with a progressive neurite extension. To investigate any role played by REST in neurodifferentiation by IGF-I, we employed an antisense oligonucleotide (AS-ODN) complementary to REST mRNA. In AS-ODN-treated cells, the effects elicited by IGF-I on cell proliferation are not influenced whereas a marked decrease of REST significantly increases neurite elongation without any gross perturbation of neurogenesis. Synapsin I and betaIII-tubulin gene promoters contain an RE-1 motif and their transcription is repressed by REST; both of them are increased in cells exposed to IGF-I for 5 days and further elevated by AS-ODN treatment. A parallel increase of growth cone-associated protein 43, a protein chosen as a neuronal marker not directly regulated by REST, is also observed. Therefore, REST is elevated during early steps of neural induction by IGF-I and could contribute to down-regulate genes not yet required by the differentiation program while it declines later for the acquisition of neural phenotypes. These results suggest a model in which differentiating neuroblastoma cells determine their extent of neurite outgrowth on the basis of REST disappearance.


Assuntos
Diferenciação Celular/efeitos dos fármacos , Regulação da Expressão Gênica/efeitos dos fármacos , Fator de Crescimento Insulin-Like I/farmacologia , Proteínas Repressoras/metabolismo , Fatores de Transcrição/metabolismo , Anticorpos/farmacologia , Western Blotting/métodos , Diferenciação Celular/fisiologia , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Meios de Cultura Livres de Soro/farmacologia , Interações Medicamentosas , Ensaio de Desvio de Mobilidade Eletroforética/métodos , Ativação Enzimática/efeitos dos fármacos , Proteína GAP-43/metabolismo , Humanos , Imuno-Histoquímica/métodos , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Neuritos/efeitos dos fármacos , Neuroblastoma , Oligodesoxirribonucleotídeos Antissenso/farmacologia , RNA Mensageiro/biossíntese , Proteínas Repressoras/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Sinapsinas/metabolismo , Timidina/farmacocinética , Fatores de Tempo , Fatores de Transcrição/genética , Trítio/farmacocinética , Tubulina (Proteína)/metabolismo
5.
Peptides ; 25(4): 571-5, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15165711

RESUMO

Twelve patients with chronic critical limb ischemia in whom a spinal cord stimulation (SCS) system had been implanted for at least one year had increased microvascular flow and achieved healing of trophic acral lesions. After switching off the system, the clinical improvement persisted for 10 days and the neurohormonal pattern showed high plasma values of beta-endorphin and Met-enkephalin, normal dynorphin B, endothelin-1 and catecholamines, and low nitric oxide. Met-enkephalin levels were further increased (P < 0.01) immediately after switching on the electrical stimulation again. The persistence of high plasma opioid levels after switching off the spinal cord stimulation explains the absence of subjective complaints and suggests an involvement of opioids in the regulation and improvement of the microcirculation.


Assuntos
Isquemia/sangue , Extremidade Inferior/patologia , Microcirculação , Peptídeos Opioides/sangue , Extremidade Superior/patologia , Adulto , Catecolaminas/sangue , Terapia por Estimulação Elétrica , Endotelina-1/sangue , Feminino , Humanos , Isquemia/fisiopatologia , Isquemia/terapia , Extremidade Inferior/irrigação sanguínea , Masculino , Microcirculação/fisiologia , Pessoa de Meia-Idade , Óxido Nítrico/sangue , Medula Espinal , Extremidade Superior/irrigação sanguínea
6.
Eur J Pharm Sci ; 21(2-3): 161-9, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14757487

RESUMO

The biocompatibility of polylactic acid (PLA) and polyglycolic acid (PGA) copolymers, employed in manufacturing bone-graft substitutes, is affected by their chemical composition, molecular weight and cell environment, and by the methods of polymerization and processing. Their in vitro bioactivity on human osteoblasts has been investigated very little. We first evaluated the behavior of primary human osteoblasts cultured in close contact with 75:25 and 50:50 PLA-PGA copolymers for 14 days adopting a cell culture system that allowed us to evaluate the influence of direct contact, and of factors released from polymers. The copolymers had no negative influence on cell morphology, cell viability and proliferation. Alkaline phosphatase (ALP) activity and osteocalcin production were also not affected. The initial adhesion of osteoblasts on implant surfaces requires the contribution of integrins, acting as a primary mechanism regulating cell-extracellular matrix (ECM) interactions. We observed that adhesion of osteoblasts to PLA-PGA copolymers, 2h after plating, was reduced by approximately 70% by antibodies capable to block integrin beta(1) and alpha(5)beta(1) complex and only by approximately 30% by an anti-integrin alpha(v) antibody. Therefore, beta(1) integrins may represent a predominant adhesion receptor subfamily utilized by osteoblasts to adhere to PLA-PGA copolymers. These materials do not show any negative influence on cell proliferation and differentiation.


Assuntos
Materiais Biocompatíveis/metabolismo , Portadores de Fármacos/metabolismo , Integrinas/metabolismo , Ácido Láctico/metabolismo , Osteoblastos/fisiologia , Ácido Poliglicólico/metabolismo , Polímeros/metabolismo , Fosfatase Alcalina/biossíntese , Anticorpos/farmacologia , Materiais Biocompatíveis/toxicidade , Adesão Celular , Divisão Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Células Cultivadas , Portadores de Fármacos/toxicidade , Humanos , Integrinas/antagonistas & inibidores , Ácido Láctico/toxicidade , Osteoblastos/química , Osteoblastos/metabolismo , Osteocalcina/biossíntese , Ácido Poliglicólico/toxicidade , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Polímeros/toxicidade , Fatores de Tempo
7.
J Org Chem ; 61(23): 8285-8292, 1996 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-11667817

RESUMO

The action of FeCl(3) on 3-(alkylsulfanyl)thiophenes (3-(alkylthio)thiophenes) leads to the one-step formation of regioregular alpha-conjugated oligothiophenes, from trimer to octamer, depending on the solvent used and on the length of the alkyl chain. The regiochemistry of these oligomers is characterized by one inner head-to-head linkage between adjacent rings and by a variable number of lateral head-to-tail junctions. The reaction of ferric chloride with the head-to-head and head-to-tail bis(methylsulfanyl)-2,2'-bithiophenes gives the corresponding tetramers, while the reaction with the tail-to-tail counterpart affords a high molecular weight insoluble material. With the aid of theoretical calculations, these results are interpreted on the basis of the joint effects of the orienting power of the substituents and of the stability of the radical cations formed during the oxidative process.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...